Loading...

ADC Therapeutics SA (NYSE:ADCT)

7.89 USD +1.01 USD ( +14.68% )
Watchlist Manager
ADC Therapeutics SA
NYSE:ADCT
Watchlist

ROA
Return on Assets

ROA is an indicator of how well a company utilizes its assets in terms of profitability.

This number tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control.

ROA
=
Net Income
/
Total Assets
Current ROA
ADCT
-37.4%
Average ROA
ADCT
-55%
Industry ROA
Biotechnology
-12.1%

ROA History

Statistics
Return on Assets

1 Year 3 Years 5 Years
Average -50.8% -55% -55%
Median -43.4% -45.6% -45.6%
Min -84.9% -84.9% -84.9%
Max -37.4% -37.4% -37.4%

History Chart
Return on Assets

ROA Across Competitors

ROA Comparison
ADC Therapeutics SA Competitors

Country Company Market Cap ROA
CH
ADC Therapeutics SA
NYSE:ADCT
606M USD
-37%
US
Abbvie Inc
NYSE:ABBV
269B USD
9%
US
Amgen Inc
NASDAQ:AMGN
131B USD
9%
AU
CSL Ltd
ASX:CSL
128B AUD
11%
US
Gilead Sciences Inc
NASDAQ:GILD
79.2B USD
7%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
74.8B USD
19%
Country CH
Market Cap 606M USD
ROA
-37%
Country US
Market Cap 269B USD
ROA
9%
Country US
Market Cap 131B USD
ROA
9%
Country AU
Market Cap 128B AUD
ROA
11%
Country US
Market Cap 79.2B USD
ROA
7%
Country US
Market Cap 74.8B USD
ROA
19%

Profitability Report

View the profitability report to see the full profitability analysis for ADC Therapeutics SA.

See Also

Similar Stocks